In my opinion there are a few factors keeping a lid on the AVR...

In my opinion there are a few factors keeping a lid on the AVR share price.

barracudaking's point regarding the Star Bright Group is arguably the primary reason for the current predicament after their 2018 receipt of more than 70 million shares, so it's going to take time before they are off the scene.

Also AVR is still in its infancy as a biotech company and its world class product is still a few years away from monetising it.

And since the commencement of the first-in-human 15-patient SAVR study of its DurAVRTM 3D single-piece aortic valve following approval by the Federal Agency for Medicines and Health Products (FAMHP) of Belgium in March, there have been a reported six successful operations and WP has stated he will not be making another progress report until that reaches eight.

So all - in - all I'm tipping we have another three years to wait before we pop the corks, so accumulation at bargain base prices is the way to go.